A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus
New England Journal of MedicinePublished 18 September 1997Open access
Christopher C. Whalen, John L. Johnson, Alphonse Okwera, David L. Hom, Robin Huebner, Peter Mugyenyi
Citations391
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A six-month course of isoniazid confers short-term protection against tuberculosis among PPD-positive, HIV-infected adults and multidrug regimens with isoniaZid and rifampin taken for three months also reduce the risk of tuberculosis.
Abstract
A six-month course of isoniazid confers short-term protection against tuberculosis among PPD-positive, HIV-infected adults. Multidrug regimens with isoniazid and rifampin taken for three months also reduce the risk of tuberculosis.
Keywords
Medicine
BiometrikaDiscrete sequential boundaries for clinical trials
1,740 Citations1983K. K. Gordon Lan, David L. DeMets
A more flexible way to construct discrete sequential boundaries is proposed, based on the choice of a function, a*(t), which characterizes the rate at which the error level ac is spent.
New England Journal of MedicineA Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
1,579 Citations1989Peter A. Selwyn, Diana Hartel +6 more
The data suggest that in HIV-infected persons tuberculosis most often results from the reactivation of latent tuberculous infection; these results lend support to recommendations for the aggressive use of chemoprophylaxis against tuberculosis in patients with HIV infection and a positive PPD test.
New England Journal of MedicineTreatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus Infection
484 Citations1991Peter M. Small, Gisela Schecter +4 more
Tuberculosis causes substantial mortality in patients with advanced HIV infection and in patients who comply with the regimen, conventional therapy results in rapid sterilization of sputum, radiographic improvement, and low rates of relapse.
New England Journal of MedicineCutaneous Disease and Drug Reactions in HIV Infection
482 Citations1993Serge A. Coopman, Richard A. Johnson +2 more
Cutaneous diseases, including drug reactions, are extremely common in patients with HIV infection, and their incidence increases as immune function deteriorates.
American Review of Respiratory DiseaseTuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and Survival
460 Citations1987Richard E. Chaisson, Gisela Schecter +4 more
Response to antituberculosis therapy was favorable in AIDS patients, although adverse drug reactions occurred more frequently than in non-AIDS patients (p less than 0.02).
The LancetEffect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
438 Citations1993Jean W. Pape, SIMONE S. JEAN +3 more
Isoniazid prophylaxis should be considered for HIV-seropositive, P PD-positive subjects, and may also be appropriate for PPD-negative patients in areas where tuberculosis is highly endemic.
American Review of Respiratory DiseaseDiagnostic Standards and Classification of Tuberculosis
432 Citations1991Lloyd N. Friedman
Tubercle and Lung DiseaseHIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention
332 Citations1992J P Narain, Mario Raviǵlione +1 more
The highest priority must be given to strengthening tuberculosis control programmes in the countries where they are poorly developed and where the prevalence of HIV and tuberculosis infections is high, including BCG vaccination and preventive chemotherapy among HIV-infected individuals.
American Review of Respiratory DiseaseA Double-blind Placebo-controlled Clinical Trial of Three Antituberculosis Chemoprophylaxis Regimens in Patients with Silicosis in Hong Kong
305 Citations1992Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council
There was no evidence that chemoprophylaxis led to the selection of drug-resistant strains of bacilli, and adverse effects were reported with a similar frequency in all four series, suggesting that few were drug related.
JAMAHigh Risk of Active Tuberculosis in HIV-Infected Drug Users With Cutaneous Anergy
288 Citations1992Peter A. Selwyn
The results support the routine use of delayed-type hypersensitivity testing for drug injectors with known or suspected HIV infection, and consideration of isoniazid prophylaxis for anergic as well as tuberculin-reactive subjects who are HIV seropositive, in populations with a high prevalence of coexisting HIV and Mycobacterium tuberculosis infection.
PubMedIsoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
241 Citations1979G W Comstock, C Baum +1 more
The results of the study are consistent with the hypothesis that the decrease in risk of tuberculosis produced by isoniazid preventive therapy is lifelong.
JAMARisk Factors for Tuberculosis in HIV-lnfected Persons
220 Citations1995Giorgio Antonucci
Risk of tuberculosis in HIV-infected persons can be more precisely quantified by jointly considering skin test reactivity and CD4+lymphocyte count and periodic skin tests in tuberculin-negative nonanergic individuals can be useful in identifying individuals at high risk of active tuberculosis.
The LancetResponse to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire
211 Citations1995Alain Ackah, H. Digbeu +6 more
Severity of immune deficiency was the major determinant of mortality in HIV-associated tuberculosis in Côte d'Ivoire and microbiological response was satisfactory irrespective of serological or immune status.
AIDSA prospective study of the risk of tuberculosis among HIV-infected patients
177 Citations1993Ana Guelar, José M. Gatell +9 more
Among HIV-infected patients in whom the tuberculin skin test is negative, the risk of developing active TB is sufficient to consider prophylaxis if the CD4 count falls below 400 $$ 106/l, at least in those patients with skin anergy living in high-risk geographical areas such as Spain.
Archives of Internal MedicineDrug Dependence, A Possible New Risk Factor for Tuberculosis Disease
174 Citations1979Lee B. Reichman
It is suggested that infected drug-dependent persons (tuberculin positive) be considered for preventive therapy with isoniazid, which can be piggybacked onto a drug treatment program.
Annals of Internal MedicineRisk for Developing Tuberculosis among Anergic Patients Infected with HIV
174 Citations1993Santiago Moreno, Josu Baraia-Etxaburu +8 more
The risk for developing tuberculosis among anergic and nonanergic HIV-infected persons and the convenience of broadening the indications of chemoprophylaxis to anergic patients in this area was assessed.
American Review of Respiratory DiseaseCohort Study of Human Immunodeficiency Virus Infection in Patients with Tuberculosis in Nairobi, Kenya: Analysis of Early (6-Month) Mortality
168 Citations1992Paul Nunn, Richard Brindle +8 more
Tuberculosis control programs in developing countries need to implement "short-course" regimens and train health workers to recognize and treat nontuberculous infections to maintain their effectiveness in the face of the HIV epidemic.
American Review of Respiratory DiseaseIncreased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, Zaire
162 Citations1991Joseph H. Perriëns, Robert Colebunders +9 more
Given their higher relapse rate after 1 yr of "standard" chemotherapy, the public health impact of routine maintenance therapy in HIV seropositive patients with pulmonary TB who complete such therapy should be assessed in comparison to the introduction of rifampicin-based short-course antituberculosis chemotherapy in developing countries.
American Review of Respiratory DiseaseExperimental Short-course Preventive Therapy of Tuberculosis with Rifampin and Pyrazinamide
150 Citations1989Herve F. Lecoeur, C. Truffot-Pernot +1 more
In a first experiment, the efficacy of a 6-month course of isoniazid (INH) alone in comparison with 2-month courses of rifampin (RMP) alone, R MP + pyrazinamide (PZA), or RMP + PZA + INH as preventive therapy of tuberculosis was evaluated in the mouse.
JAMARisk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)
148 Citations1995G. Antonucci
Risk of tuberculosis in HIV-infected persons can be more precisely quantified by jointly considering skin test reactivity and CD4+ lymphocytes in the three groups of subjects with different skin test responsiveness.
New England Journal of MedicineDrug Malabsorption and Resistant Tuberculosis in HIV-Infected Patients
119 Citations1995Kalpana B. Patel, Romelle Belmonte +1 more
To the Editor: Directly observed therapy for tuberculosis has been advocated as a way to improve compliance and control the emergence of drug resistance.
New England Journal of MedicineMalabsorption of Antimycobacterial Medications
119 Citations1993Charles A. Peloquin, Allan A. MacPhee +1 more
Serum concentrations of antimycobacterial drugs in all samples submitted to the authors' laboratory between January 1 and July 31, 1993 were reviewed and all assays were extensively validated and were specific for the drugs of .
New England Journal of MedicineAIDS in Uganda — Clinical and Social Features
109 Citations1990Richard Goodgame
The clinical and social features of the AIDS epidemic in Uganda are highlighted, with 1 million adults out of a country of 17 million people estimated to be HIV-seropositive.
JAMAHigh risk of active tuberculosis in HIV-infected drug users with cutaneous anergy
81 Citations1992Peter A. Selwyn
The LancetPreventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice
68 Citations1995Kevin M. De Cock, Alison D. Grant +1 more
The authors briefly discuss preventive therapy for TB in HIV-infected persons, research issues, and the international role of preventive therapy.
Annals of Internal MedicineTuberculosis Control and the AIDS Epidemic in Developing Countries
63 Citations1990Arthur E. Pitchenik
The acquired immunodeficiency syndrome (AIDS) epidemic poses profound problems for the control of tuberculosis in developing countries and needs to be addressed, says the World Health Organization.
American Journal of Respiratory and Critical Care MedicinePredictors of Survival in Human Immunodeficiency Virus-Infected Patients With Pulmonary Tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration
62 Citations1996Christopher C. Whalen, Alphonse Okwera +7 more
Four simple and inexpensive predictors of survival were found in HIV-infected Ugandan adults with smear-positive pulmonary tuberculosis and factors suggest that the degree of immunosuppression was a major determinant of survival.
Archives of Internal MedicineEffect of Isoniazid Chemoprophylaxis on HIV-Related Mycobacterial Disease
51 Citations1996Neil M.H. Graham
Expanded access to directly observed isonazid therapy for tuberculin-positive IDUs with and without HIV infection was associated with an 83% drop in tuberculosis incidence, while in the same period M avium complex incidence significantly increased.
AIDSThe influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa
50 Citations1992Anton Pozniak, Gillian A. MacLeod +3 more
The use of thiacetazone and streptomycin in antituberculous drug regimens should be reassessed in those countries where coinfection with HIV and tuberculosis is common.
AIDSPreventive therapy for tuberculosis in HIV infection
38 Citations1995Richard O’Brien, Joseph H. Perriëns
Recommendation is the approach adopted in the US of providing a six-month course of isoniazid to those with a positive tuberculin skin test reaction and epidemiologic risk factors; for those already infected with HIV, 12 months of treatment is suggested.
Archives of Internal MedicineDrug dependence, a possible new risk factor for tuberculosis disease
30 Citations1979L. B. Reichman